Anticoagulants, Antiplatelets & Thrombolytics Explained

When blood needs to stop leaking from a cut, the body builds a clot in two stages: platelets clump together to form a plug, and then a chain reaction called the coagulation cascade weaves fibrin threads that cement the plug in place. Anticoagulants slow down the cascade, antiplatelets stop platelets from clumping, and thrombolytics dissolve clots that have already formed.

This matters because unwanted clots kill. A clot in a coronary artery causes a heart attack, a clot travelling to the brain causes an ischemic stroke, and clots in the legs or lungs cause deep vein thrombosis and pulmonary embolism.

Key Concepts

• Heparin: unfractionated heparin (UFH, IV infusion) and low-molecular-weight heparin such as enoxaparin (subcutaneous). Monitored with aPTT; reversed with protamine.
• Warfarin: blocks vitamin K recycling, lowering functional factors II, VII, IX and X. Monitored with INR (target usually 2.0 to 3.0). Reversed with vitamin K and 4-factor prothrombin complex concentrate.
• DOACs: direct oral anticoagulants. Dabigatran blocks thrombin directly; rivaroxaban, apixaban and edoxaban block factor Xa directly. No routine monitoring, but doses depend on kidney function.
• Antiplatelets: aspirin blocks COX-1 irreversibly; clopidogrel, prasugrel and ticagrelor block the platelet P2Y12 ADP receptor; abciximab, eptifibatide and tirofiban block the GP IIb/IIIa receptor.

Formulas

• Heparin bolus: 80 units per kg body weight (IV push).
• Heparin infusion: 18 units per kg per hour, titrated to keep aPTT at 1.5 to 2.5 times the control value.
• Kidney function (Cockcroft-Gault): creatinine clearance (mL/min) = (140 minus age) times weight in kg, divided by (72 times serum creatinine in mg/dL); multiply by 0.85 for women. DOAC doses are reduced when this falls below set cut-offs.

Worked Example

A 70 kg patient arrives with an acute coronary syndrome and needs a heparin infusion. Step 1: bolus = 80 units/kg times 70 kg = 5,600 units IV. Step 2: infusion rate = 18 units/kg/hour times 70 kg = 1,260 units per hour. Now check kidney function for a later switch to rivaroxaban: a 70-year-old man weighing 70 kg with creatinine 1.2 mg/dL gives (140 minus 70) times 70 divided by (72 times 1.2) = 4,900 divided by 86.4 = 56.7 mL/min. Since this is above 50 mL/min, the standard 20 mg once-daily dose applies rather than the reduced 15 mg dose.

Common Misconceptions

• "Blood thinners make the blood thinner." They do not change blood thickness or viscosity at all; they only slow the chemical steps of clotting. The blood looks and flows exactly the same.
• "Everyone over 50 should take daily aspirin." Aspirin prevents clots but causes stomach and brain bleeding. It is recommended only where the clotting risk clearly outweighs the bleeding risk, such as after a heart attack or stent.
• "You can stop warfarin suddenly once you feel fine." Stopping an anticoagulant abruptly returns clotting risk to full within days, so any stop must be planned with the doctor.

Real-World Applications

• Stroke prevention in atrial fibrillation, where a quivering atrium lets clots form and travel to the brain.
• Treatment and prevention of deep vein thrombosis and pulmonary embolism after surgery or long immobility.
• Dual antiplatelet therapy (aspirin plus a P2Y12 blocker) keeps coronary stents open after angioplasty.
• Thrombolysis with alteplase within 4.5 hours of an ischemic stroke, and with tenecteplase as a single bolus for ST-elevation heart attack where angioplasty is delayed.

Anticoagulants slow the clotting cascade, antiplatelets stop platelet clumping, and thrombolytics dissolve clots already formed. Heparin and warfarin need lab monitoring while DOACs need kidney-based dosing, and every one of these drugs trades clot prevention against bleeding risk. they prevent strokes, heart attacks and fatal embolisms every day.